Document Detail

Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder.
MedLine Citation:
PMID:  17630258     Owner:  NLM     Status:  MEDLINE    
A variety of studies have suggested that glutamatergic neurotransmission is altered in schizophrenia and bipolar disorder. Here, we tested if plasma glutamate levels are altered in 56 patients diagnosed with schizophrenia, bipolar disorder or non-specified psychosis at the first psychotic episode and at various stages during one-year follow-up. A decrease in the levels of plasma glutamate was observed in all groups of patients at the first psychotic episode. Furthermore, plasma glutamate levels were restored after treatment in all instances. Decreased plasma glutamate levels at first psychotic episodes may reflect impaired glutamate signaling during the initial stages of schizophrenia and bipolar disorder.
Aitor Palomino; Ana González-Pinto; Ana Aldama; Cristina González-Gómez; Fernando Mosquera; Gixane González-García; Carlos Matute
Related Documents :
7591698 - Serum enzyme activities following long-distance running: comparison between ethiopian a...
10023318 - Serum gamma-glutamyltransferase and alkaline phosphatase during experimental liver meta...
2393108 - Hepatocellular integrity in swine after prolonged desflurane (i-653) and isoflurane ane...
16880138 - The relationship between anthropometry and serum concentrations of alkaline phosphatase...
11385598 - Proteomic comparison of human and great ape blood plasma reveals conserved glycosylatio...
3989428 - Plasma and tissue concentrations of melatonin after midnight light exposure and pineale...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-07-13
Journal Detail:
Title:  Schizophrenia research     Volume:  95     ISSN:  0920-9964     ISO Abbreviation:  Schizophr. Res.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-09-03     Completed Date:  2007-10-24     Revised Date:  2010-09-02    
Medline Journal Info:
Nlm Unique ID:  8804207     Medline TA:  Schizophr Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  174-8     Citation Subset:  IM    
Neurotek UPV-EHU, Parque Tecnológico de Bizkaia, E-48170 Zamudio, Vizcaya, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amino Acid Transport System X-AG / drug effects,  physiology
Antipsychotic Agents / pharmacology,  therapeutic use
Bipolar Disorder / blood*,  drug therapy,  physiopathology
Follow-Up Studies
Glutamates / blood*,  drug effects,  physiology
Longitudinal Studies
Psychiatric Status Rating Scales / statistics & numerical data
Psychotic Disorders / blood,  drug therapy,  physiopathology
Schizophrenia / blood*,  drug therapy,  physiopathology
Synaptic Transmission / drug effects,  physiology
Reg. No./Substance:
0/Amino Acid Transport System X-AG; 0/Antipsychotic Agents; 0/Glutamates

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prospective memory in schizophrenia: primary or secondary impairment?
Next Document:  Acute psychosis leads to increased QT variability in patients suffering from schizophrenia.